Assaf Moore, Idit Peretz, Lilach Yosef, Daniel A Goldstein, Hadar Goldvaser, Suzanna Horn, Yonatan Edel, Alona Zer
{"title":"卡波西肉瘤与痛风之间的潜在联系:一项探索性观察研究。","authors":"Assaf Moore, Idit Peretz, Lilach Yosef, Daniel A Goldstein, Hadar Goldvaser, Suzanna Horn, Yonatan Edel, Alona Zer","doi":"10.1155/2020/8844970","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Kaposi sarcoma is a rare vascular mesenchymal neoplasm, associated with Human Herpes Virus 8 (HHV8). Gout is a condition clinically characterized by recurrent flares of arthritis and hyperuricemia. Following our clinical impression that patients with classical Kaposi sarcoma (CKS) have a high rate of gout, we explored this in a retrospective manner.</p><p><strong>Methods: </strong>All consecutive patients diagnosed with sarcoma or carcinosarcoma within a single tertiary center between 1/2012-12/2017 were identified through the pathology department database. A cohort of CKS patients was compared with the non-Kaposi sarcoma and carcinosarcoma cohort. Data were extracted from patients' electronic medical records. Patients younger than 18 and patients without clinical data available were excluded. Association between diagnosis of gout and CKS was assessed and adjusted for risk factors.</p><p><strong>Results: </strong>Three hundred and sixty-one patients were eligible for this analysis, 61 were diagnosed with CKS and 300 with other types of sarcoma. We found a higher incidence of gout in CKS patients, 11/61 (18%) patients, compared with 8/300 (2.6%) with other types of sarcoma, odds ratio (OR) 8.0 (<i>P</i> < 0.00001). This association persisted when adjusted for age >39 years (OR = 6.7, <i>P</i> < 0.00001), age and male sex (OR = 4.97, <i>P</i> < 0.0001), and when adjusting for multiple confounding factors and medical comorbidities.</p><p><strong>Conclusions: </strong>We have demonstrated a statistically significant association between gout and CKS. As risk factors for gout were accounted for, this association may be explained by HHV8 immune-related effects. This should be further explored in vitro and in population-based studies.</p>","PeriodicalId":21431,"journal":{"name":"Sarcoma","volume":"2020 ","pages":"8844970"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8844970","citationCount":"1","resultStr":"{\"title\":\"Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study.\",\"authors\":\"Assaf Moore, Idit Peretz, Lilach Yosef, Daniel A Goldstein, Hadar Goldvaser, Suzanna Horn, Yonatan Edel, Alona Zer\",\"doi\":\"10.1155/2020/8844970\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Kaposi sarcoma is a rare vascular mesenchymal neoplasm, associated with Human Herpes Virus 8 (HHV8). Gout is a condition clinically characterized by recurrent flares of arthritis and hyperuricemia. Following our clinical impression that patients with classical Kaposi sarcoma (CKS) have a high rate of gout, we explored this in a retrospective manner.</p><p><strong>Methods: </strong>All consecutive patients diagnosed with sarcoma or carcinosarcoma within a single tertiary center between 1/2012-12/2017 were identified through the pathology department database. A cohort of CKS patients was compared with the non-Kaposi sarcoma and carcinosarcoma cohort. Data were extracted from patients' electronic medical records. Patients younger than 18 and patients without clinical data available were excluded. Association between diagnosis of gout and CKS was assessed and adjusted for risk factors.</p><p><strong>Results: </strong>Three hundred and sixty-one patients were eligible for this analysis, 61 were diagnosed with CKS and 300 with other types of sarcoma. We found a higher incidence of gout in CKS patients, 11/61 (18%) patients, compared with 8/300 (2.6%) with other types of sarcoma, odds ratio (OR) 8.0 (<i>P</i> < 0.00001). This association persisted when adjusted for age >39 years (OR = 6.7, <i>P</i> < 0.00001), age and male sex (OR = 4.97, <i>P</i> < 0.0001), and when adjusting for multiple confounding factors and medical comorbidities.</p><p><strong>Conclusions: </strong>We have demonstrated a statistically significant association between gout and CKS. As risk factors for gout were accounted for, this association may be explained by HHV8 immune-related effects. This should be further explored in vitro and in population-based studies.</p>\",\"PeriodicalId\":21431,\"journal\":{\"name\":\"Sarcoma\",\"volume\":\"2020 \",\"pages\":\"8844970\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2020/8844970\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sarcoma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2020/8844970\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sarcoma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8844970","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
摘要
背景:卡波西肉瘤是一种罕见的血管间充质肿瘤,与人类疱疹病毒8 (HHV8)有关。痛风是一种以反复发作的关节炎和高尿酸血症为临床特征的疾病。根据我们的临床印象,经典卡波西肉瘤(CKS)患者有很高的痛风率,我们以回顾性的方式探讨了这一点。方法:在2012年1月至2017年12月期间,通过病毒科数据库确定所有在单一三级中心连续诊断为肉瘤或癌性肉瘤的患者。将一组CKS患者与非卡波西肉瘤和癌肉瘤患者进行比较。数据从患者的电子病历中提取。年龄小于18岁的患者和没有临床资料的患者被排除在外。评估痛风诊断与CKS之间的关系,并根据危险因素进行调整。结果:361例患者符合分析条件,其中61例诊断为CKS, 300例诊断为其他类型的肉瘤。我们发现,与其他类型的肉瘤相比,痛风在CKS患者中的发生率更高,为11/61(18%),而其他类型肉瘤的发生率为8/300(2.6%),优势比(OR)为8.0 (P < 0.00001)。当校正年龄>39岁(OR = 6.7, P < 0.00001)、年龄和男性(OR = 4.97, P < 0.0001)以及校正多种混杂因素和医学合共病时,这种相关性仍然存在。结论:我们已经证明痛风和CKS之间有统计学意义的关联。考虑到痛风的危险因素,这种关联可以用HHV8免疫相关效应来解释。这应该在体外和基于人群的研究中进一步探索。
Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study.
Background: Kaposi sarcoma is a rare vascular mesenchymal neoplasm, associated with Human Herpes Virus 8 (HHV8). Gout is a condition clinically characterized by recurrent flares of arthritis and hyperuricemia. Following our clinical impression that patients with classical Kaposi sarcoma (CKS) have a high rate of gout, we explored this in a retrospective manner.
Methods: All consecutive patients diagnosed with sarcoma or carcinosarcoma within a single tertiary center between 1/2012-12/2017 were identified through the pathology department database. A cohort of CKS patients was compared with the non-Kaposi sarcoma and carcinosarcoma cohort. Data were extracted from patients' electronic medical records. Patients younger than 18 and patients without clinical data available were excluded. Association between diagnosis of gout and CKS was assessed and adjusted for risk factors.
Results: Three hundred and sixty-one patients were eligible for this analysis, 61 were diagnosed with CKS and 300 with other types of sarcoma. We found a higher incidence of gout in CKS patients, 11/61 (18%) patients, compared with 8/300 (2.6%) with other types of sarcoma, odds ratio (OR) 8.0 (P < 0.00001). This association persisted when adjusted for age >39 years (OR = 6.7, P < 0.00001), age and male sex (OR = 4.97, P < 0.0001), and when adjusting for multiple confounding factors and medical comorbidities.
Conclusions: We have demonstrated a statistically significant association between gout and CKS. As risk factors for gout were accounted for, this association may be explained by HHV8 immune-related effects. This should be further explored in vitro and in population-based studies.
SarcomaMedicine-Radiology, Nuclear Medicine and Imaging
CiteScore
5.00
自引率
0.00%
发文量
15
审稿时长
14 weeks
期刊介绍:
Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi"s sarcoma, are published as well as preclinical and animal studies. This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients.